Meijing Li

U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors

Kyriakos P. Papadopoulos, Erkut Borazanci, Alice T. Shaw et al. · Clinical Cancer Research · 2020 · 108 citations · Full text

Medicine, Oncology, Pharmacology +15

Mixture of Activation Functions With Extended Min-Max Normalization for Forex Market Prediction

Lkhagvadorj Munkhdalai, Tsendsuren Munkhdalai, Kwang Ho Park et al. · IEEE Access · 2019 · 107 citations · Full text

Computing, Computer Science, Finance +17

Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons

Yun Chen, Ying-Han Wang, Yi Zheng et al. · Cell Reports · 2021 · 57 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Incorporating domain knowledge in chemical and biomedical named entity recognition with word representations

Tsendsuren Munkhdalai, Meijing Li, Khuyagbaatar Batsuren et al. · Journal of Cheminformatics · 2015 · 46 citations · Full text

Computing, Biochemistry, Computer Science +14

Study on the MFCC similarity-based voice activity detection algorithm

Hongzhi Wang, Yuchao Xu, Meijing Li · 2011 · 42 citations

Computing, Data Science, Acoustics +12